Relationship between hepatocellular carcinoma and impaired glucose tolerance among Japanese

Hepato-Gastroenterology

Volumn 53, Issue 71, 2006, Pages 742-746

  Khan, M M H ^a   Saito, Shigeyuki ^a   Takagi, Satoru ^a   Ohnishi, Hirofumi ^a   Izumi, Hisako ^a   Sakauchi, Fumio ^a   Washio, Masakazu ^a   Sonoda, Tomoko ^a   Nagata, Yoshie ^a   Asakura, Sumiyo ^a   Kobayashi, Kota ^a   Mori, Mitsuru ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Hepatocellular carcinoma; Impaired glucose tolerance; Japanese

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERNATIONAL CLASSIFICATION OF DISEASES; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 33750592241     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA: The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 2003; 139:817-823.
2. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
3. Yoshizawa H: Hepatocellular carcinoma associated with Hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62(Suppl 1):8-17.
4. Poynard T, Yuen M-F, Ratziu V, Lai CL: Virul hepatitis C. Lancet 2003; 362:2095-2100.
5. Kiyosawa K, Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62(Suppl 1):5-7.
6. Makimoto K, Higuchi S: Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol 1999; 28:30-34.
7. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LAM: Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963:13-20.
8. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami H-O: Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000; 92:1096-1099.
9. Yu MC, Tong MJ, Govindarajan S, Henderson BE: Nonvirul risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991; 83:1820-1826.
10. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver diseases and hepatocellular carcinoma. Gastroenterology 2004; 126:460-468.
11. Hara M, Mori M, Hara T, Yamamoto K, Honda M, Nishizumi M: Risk of developing hepatocellular carcinoma according to the titer of antibody to Hepatitis C virus. Hepatogastroenterology 2001; 48:498-501.
12. Lu SN, Lin TM, Chen CJ, et al: A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988; 62:2051-2055.
13. Kodama M, Kodama T: Interrelation between Western type cancers and non-Western type cancers as regards their risk variations in time and space. VI. Chronological transition of various cancer risks of the world from 1975 to 1985. Anticancer Res 1993; 13:2415-2420.
14. Fujino Y, Mizoue T, Tokui N, Yoshimura T: Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev 2001; 17:374-79.
15. La Vecchia C, Negri E, Decarli A, Franceschi S: Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73:204-207.
16. Adami HO, Chow WH, Nyren O, et al: Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88:1472-1477.
17. Adami HO, McLaughlin J, Ekbom A, et al: Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2:307-314.
18. Lawson DH, Gray JM, McKillop C, Clarke J, Lee FD, Patrick RS: Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986; 61:945-955.
19. Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157:1092-1100.
20. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J: Post-load plasma glucose and cancer mortality in middle-aged men and women. Am J Epidemiol 1990; 131:254-262.
21. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A: Cancer and diabetes- a follow-up study of two population-based cohorts of diabetes patients. J Intern Med 1997; 241:471-475.
22. Davey Smith G, Egger M, Shipley MJ, Marmot MG: Post-challenge glucose concentration, impaired glucose tolerance, and cancer mortality in Men. Am J Epidemiol 1992; 136:1110-1114.
23. International Union for Health Promotion and Education (IUHPE): Health promotion effectiveness - the questions to be answered. In: The evidence of health promotion effectiveness: shaping public health in a new Europe, part two. Brussels-Luxembourg; 2000, pp. 1-11.
24. Islam MM, Horibe H, Kobayashi F: Current trend in prevalence of diabetes mellitus in Japan. 1964-1992. J Epidemiol 1999; 9:155-162.
25. Neil A: Diabetes and cardiovascular disease. Diabetes Obes Metab 2003; 5(Suppl 1): S11-S18.
26. Health and Welfare Statistics Association: Kokumin eisei no doko 2002. (Trends in the nation's health, 2002). Tokyo: Kosei no shihyo, 2002. (In Japanese)
27. Xu ZR, Molyneaux L, Wang YZ, et al: Clustering of cardiovascular risk factors with diabetes in Chinese patients: the effects of sex and hyperinsulinaemia. Diabetes Obes Metab 2001; 3:157-162.
28. Saito I, Yonemasu K: Mortality among individuals diagnosed with glucose intolerance by 75 g oral glucose tolerance test in rural Japanese communities. Jpn J Public Health 2003; 50:677-685.
29. Mori M, Saitoh S, Takagi S, et al: Glucose tolerance and risk of cancer: a prospective cohort study in Hokkaido, Japan. Recent Res Devel Epidemiol 2003; 1:13-21.
30. Saitoh S, Tanaka S, Kondoh S, et al: Glucose tolerance, obesity, and hypertension: epidemiological study in Hokkaido, Japan. Anal N Y Acad Sci 1993; 676:342-344.
31. Tanaka S, Hayase A, Hashimoto A, et al: Hypertension and cardiovascular diseases in an epidemiological study in Hokkaido, Japan. J Cardiovasc Pharmacol 1990; 16(Suppl 7):S83-S86.
32. The Committee of Japan Diabetes Society for Diagnostic Criteria of Diabetes Mellitus: Report of the committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. J Japan Diab Soc 1970; 13:1-7. (In Japanese)
33. Kuzuya T: New classification and diagnostic criteria of diabetes mellitus by the Japan Diabetes Society. Asian Med J 2001; 44:49-56.
34. Bennett PH: Definition, diagnosis, and classification of diabetes mellitus and impaired glucose tolerance. In: Kahn CR, Weir GC (Eds.). Joslin's Diabetes Mellitus. 13th Edition. Media, PA: Williams & Wilkins, 1994; pp. 193-200.
35. De Giorgio R, Giovanni B, Alessandro C, Roberto C, Antonio M: Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med 2000; 160:2217.
36. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED: Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo 1998; 12:667-670.
37. Kaido T, Honda Y, Kitamura K: Association between liver dysfunction and hyperglycemia in Japanese male workers at printing and papermaking plants. J Occup Health 2002; 44:301-306.
38. Toyoda H, Kumada T, Nakano S, et al: Impact of diabetes mellitus on the progress of patients with hepatocellular carcinoma. Cancer 2001; 91:957-963.
39. Bloomgarden ZT: American Diabetes Association 60th scientific sessions, 2000: Glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics. Diabetes Care 2001; 24:779-784.